SS
RCKT icon

Sunbelt Securities’s Rocket Pharmaceuticals RCKT Stock Holding History

Sunbelt Securities’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$322 Buy
90
+28
+45% +$111 ﹤0.01% 2396
2025
Q4 		$218 Buy
62
+31
+100% +$106 ﹤0.01% 2417
2025
Q3 		$101 Buy
+31
New +$98 ﹤0.01% 2510

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sunbelt Securities's RCKT Position: Q1 2026 in Review

Sunbelt Securities increased its Rocket Pharmaceuticals (RCKT) stake by 45% in Q1 2026, buying an estimated $111 and bringing the position to 90 shares worth $322. The position accounts for ﹤0.01% of the portfolio, ranked #2396.

Sunbelt Securities first reported a position in RCKT in Q3 2025 and has held it in 3 quarters since. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Sunbelt Securities held 90 shares of Rocket Pharmaceuticals worth $322 as of Q1 2026.
  • Sunbelt Securities bought 28 Rocket Pharmaceuticals shares in Q1 2026, an estimated $111.
  • Rocket Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2396 holding.
  • Sunbelt Securities first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.